chloroquine has been researched along with Erythema in 26 studies
Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.
Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of disease processes.
Excerpt | Relevance | Reference |
---|---|---|
"Chloroquine induced a myasthenic syndrome in a patient taking the drug for presumable reticular erythematous mucinosis." | 8.77 | Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction. ( Bednarik, J; Bourgeois, P; Carton, H; Robberecht, W; van Hees, J, 1989) |
"Chloroquine (CQ) is a prototypical systemic and intradermal pruritogen for histamine-independent (nonhistaminergic) itch in mice and humans." | 5.56 | Characterization of a chloroquine-induced canine model of pruritus and skin inflammation. ( Banovic, F; Blubaugh, A; Denley, T, 2020) |
"Chloroquine was started at a dose of 4 mg/kg daily for 10 days, then 250 mg daily for next the 10 weeks, resulting in complete clearance of all the lesions, which was sustained for over 2 years of follow-up." | 5.48 | Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine. ( Bartolić, L; Bradamante, M; Ljubojević Hadžavdić, S, 2018) |
"Chloroquine induced a myasthenic syndrome in a patient taking the drug for presumable reticular erythematous mucinosis." | 4.77 | Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction. ( Bednarik, J; Bourgeois, P; Carton, H; Robberecht, W; van Hees, J, 1989) |
"Chloroquine (CQ) is a prototypical systemic and intradermal pruritogen for histamine-independent (nonhistaminergic) itch in mice and humans." | 1.56 | Characterization of a chloroquine-induced canine model of pruritus and skin inflammation. ( Banovic, F; Blubaugh, A; Denley, T, 2020) |
"Chloroquine was started at a dose of 4 mg/kg daily for 10 days, then 250 mg daily for next the 10 weeks, resulting in complete clearance of all the lesions, which was sustained for over 2 years of follow-up." | 1.48 | Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine. ( Bartolić, L; Bradamante, M; Ljubojević Hadžavdić, S, 2018) |
"Reticular erythematous mucinosis (REM) is an uncommon disease, the nosology and specific characteristics of which are controversial because most reports deal with single cases or small series." | 1.39 | Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases. ( Cinotti, E; Cozzani, E; Ghigliotti, G; Kanitakis, J; Merlo, V; Parodi, A; Riva, S; Rongioletti, F, 2013) |
"Reticular erythematous mucinosis (REM syndrome) is a rare cutaneous disease that predominantly affects the chest and upper back area of middle-aged women." | 1.37 | Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis: a case series of 11 patients. ( Altmeyer, P; Gambichler, T; Kreuter, A; Scola, N; Tigges, C, 2011) |
"Chlorpromazine was used as a model drug irritant." | 1.30 | Reverse iontophoresis: monitoring prostaglandin E2 associated with cutaneous inflammation in vivo. ( Buttery, M; Cormier, M; Daddona, P; Mize, NK; Morales, C, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (73.08) | 18.7374 |
1990's | 2 (7.69) | 18.2507 |
2000's | 1 (3.85) | 29.6817 |
2010's | 3 (11.54) | 24.3611 |
2020's | 1 (3.85) | 2.80 |
Authors | Studies |
---|---|
Blubaugh, A | 1 |
Denley, T | 1 |
Banovic, F | 1 |
Ljubojević Hadžavdić, S | 1 |
Bartolić, L | 1 |
Bradamante, M | 1 |
Rongioletti, F | 1 |
Merlo, V | 1 |
Riva, S | 1 |
Cozzani, E | 1 |
Cinotti, E | 1 |
Ghigliotti, G | 1 |
Parodi, A | 1 |
Kanitakis, J | 1 |
Onken, AT | 1 |
Belloni, B | 1 |
Schnopp, C | 1 |
Hein, R | 1 |
Mempel, M | 1 |
Ring, J | 1 |
Kreuter, A | 1 |
Scola, N | 1 |
Tigges, C | 1 |
Altmeyer, P | 1 |
Gambichler, T | 1 |
BLAICH, W | 1 |
GERLACH, U | 1 |
WALTHER, D | 1 |
REHTIJARVI, K | 1 |
OLIVARES BAQUE, C | 1 |
MARRON GASCA, J | 1 |
DE AZAGRA, JV | 1 |
ARROYO, H | 1 |
JAEHRIG, K | 1 |
THIES, W | 1 |
Ashurst, PJ | 1 |
Claudy, AL | 1 |
Kint, A | 1 |
de Cuyper, C | 1 |
Sjölin-Forsberg, G | 1 |
Berne, B | 1 |
Eggelte, TA | 1 |
Karlsson-Parra, A | 1 |
Mize, NK | 1 |
Buttery, M | 1 |
Daddona, P | 1 |
Morales, C | 1 |
Cormier, M | 1 |
Robberecht, W | 1 |
Bednarik, J | 1 |
Bourgeois, P | 1 |
van Hees, J | 1 |
Carton, H | 1 |
Wozel, G | 1 |
Barth, J | 1 |
Rowell, NR | 1 |
Mahoney, MG | 1 |
Wood, MG | 1 |
Wilson, F | 1 |
Goerttler, E | 1 |
Chung, J | 1 |
Song, CW | 1 |
Tamaguchi, T | 1 |
Tabachnick, J | 1 |
Lester, RS | 1 |
Burnham, TK | 1 |
Fine, G | 1 |
Murray, K | 1 |
Adams, SS | 1 |
Knox, JM | 1 |
Dodge, BG | 1 |
Freeman, RG | 1 |
1 review available for chloroquine and Erythema
Article | Year |
---|---|
Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction.
Topics: Adult; Chloroquine; Electric Stimulation; Electromyography; Erythema; Female; Humans; Injections; Ma | 1989 |
25 other studies available for chloroquine and Erythema
Article | Year |
---|---|
Characterization of a chloroquine-induced canine model of pruritus and skin inflammation.
Topics: Administration, Intravenous; Animals; Chloroquine; Cross-Over Studies; Disease Models, Animal; Dogs; | 2020 |
Prolonged Treatment of Eosinophilic Erythema Annulare with Chloroquine.
Topics: Antimalarials; Chloroquine; Eosinophilia; Erythema; Humans; Male; Middle Aged; Skin Diseases, Geneti | 2018 |
Reticular erythematous mucinosis: a review of patients' characteristics, associated conditions, therapy and outcome in 25 cases.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibodies, Antinucl | 2013 |
[Reticular erythematous plaques].
Topics: Administration, Topical; Adult; Antirheumatic Agents; Chloroquine; Erythema; Female; Humans; Pannicu | 2009 |
Clinical features and efficacy of antimalarial treatment for reticular erythematous mucinosis: a case series of 11 patients.
Topics: Adult; Antimalarials; Chloroquine; Comorbidity; Erythema; Female; Humans; Male; Middle Aged; Mucinos | 2011 |
[Effective mechanisms of resochin in erythematodes].
Topics: Chloroquine; Erythema | 1955 |
[Resochin treatment of chronic erythema; clinical therapeutic report].
Topics: Chloroquine; Erythema | 1955 |
Two cases of chronic disseminated lupus erythematodes treated successively with ACTH, cortisone and chloroquine.
Topics: Adrenocorticotropic Hormone; Chloroquine; Collagen Diseases; Cortisone; Erythema; Lupus Erythematosu | 1957 |
[Contribution to the treatment of chronic erythema with resochin and vitamin B-12].
Topics: Chloroquine; Erythema; Vitamin B 12; Vitamins | 1960 |
[Apropos of 2 cases of Debra's multiform exudative erythema with mucosa attacks (so-called Stevens and Johnson, or Rendu and Fiessinger syndrome) treated with chloroquine].
Topics: Animals; Behavior, Animal; Chloroquine; Erythema; Erythema Multiforme; Humans; Mucous Membrane; Soci | 1961 |
[CHLORQUINDIPHOSPHATE AND CUTANEOUS PIGMENTS].
Topics: Child; Chloroquine; Dermatitis, Phototoxic; Drug Therapy; Erythema; Melanins; Photosensitivity Disor | 1965 |
[Recent experience in the treatment of erythematodes chronicus discoides with atebrin and resochin, with special reference to local and combined therapeutic methods].
Topics: Chloroquine; Combined Modality Therapy; Erythema; Humans; Quinacrine | 1955 |
Erythema annulare centrifugum due to hydroxychloroquine sulfate and chloroquine sulfate.
Topics: Adult; Aged; Antimalarials; Chloroquine; Erythema; Female; Humans; Hydroxychloroquine; Lupus Erythem | 1967 |
[R.E.M. syndrome or idiopathic reticular erythema].
Topics: Chloroquine; Erythema; Humans; Male; Middle Aged; Syndrome | 1980 |
[Erythema elevatum diutinum].
Topics: Aged; Chloroquine; Erythema; Female; Humans; Recurrence | 1980 |
In situ localization of chloroquine and immunohistological studies in UVB-irradiated skin of photosensitive patients.
Topics: Adolescent; Adult; Chloroquine; Endothelium, Vascular; Erythema; Female; Gene Expression Regulation; | 1995 |
Reverse iontophoresis: monitoring prostaglandin E2 associated with cutaneous inflammation in vivo.
Topics: Amebicides; Anesthetics, Local; Animals; Antiemetics; Arginine Vasopressin; Biological Transport; Bl | 1997 |
[The REM syndrome--alternative therapeutic possibilities].
Topics: Adult; Chloroquine; Dapsone; Erythema; Female; Humans; Mucins; PUVA Therapy | 1987 |
Systemic lupus erythematosus.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Antinuclear; Autoantibodies; Chloroquine; Erythema; Fema | 1969 |
Erythema elevatum diutinum.
Topics: Adrenocorticotropic Hormone; Adult; Anti-Bacterial Agents; Antimalarials; Chloroquine; Erythema; Fem | 1968 |
[Erythema elevatum diutinum with alopecic changes].
Topics: Adult; Alopecia; Capillaries; Chloroquine; Diagnosis, Differential; Erythema; Humans; Leprosy; Lupus | 1973 |
Effect of anti-inflammatory compounds on -irradiation induced radiodermatitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Chloroquine; Drug Combinations; Erythema; G | 1972 |
Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine.
Topics: Antibodies, Antinuclear; Autoantibodies; Chloroquine; DNA; Erythema; Humans; Hydralazine; Hydroxychl | 1967 |
The development of an antirheumatic drug.
Topics: Adrenal Cortex Hormones; Analgesics; Animals; Anti-Inflammatory Agents; Aspirin; Cats; Chloroquine; | 1971 |
Erythema dyschromicum perstans.
Topics: Adolescent; Adult; Biopsy; Blood Cell Count; Blood Sedimentation; Child, Preschool; Chloroquine; Ery | 1968 |